| Symbol |
Name |
|
AAGAB
|
alpha- and gamma-adaptin binding protein
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADIRF
|
adipogenesis regulatory factor
|
|
ADNP
|
activity-dependent neuroprotector homeobox
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKTIP
|
AKT interacting protein
|
|
ALB
|
albumin
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPP
|
alkaline phosphatase, placental
|
|
AMH
|
anti-Mullerian hormone
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANXA2
|
annexin A2
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARL11
|
ADP-ribosylation factor-like 11
|
|
ASPA
|
aspartoacylase
|
|
ATG5
|
autophagy related 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
B2M
|
beta-2-microglobulin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BGN
|
biglycan
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BSG
|
basigin (Ok blood group)
|
|
BSPH1
|
binder of sperm protein homolog 1
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCRL
|
calcitonin receptor-like
|
|
CANT1
|
calcium activated nucleotidase 1
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CARD10
|
caspase recruitment domain family, member 10
|
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND3
|
cyclin D3
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD34
|
CD34 molecule
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD69
|
CD69 molecule
|
|
CD70
|
CD70 molecule
|
|
CD81
|
CD81 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPA
|
centromere protein A
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIDEA
|
cell death-inducing DFFA-like effector a
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
|
CIDEC
|
cell death-inducing DFFA-like effector c
|
|
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
|
|
CKM
|
creatine kinase, muscle
|
|
CLDN7
|
claudin 7
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLIP2
|
CAP-GLY domain containing linker protein 2
|
|
CLU
|
clusterin
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COCH
|
cochlin
|
|
COIL
|
coilin
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPE
|
carboxypeptidase E
|
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CSE1L
|
CSE1 chromosome segregation 1-like (yeast)
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB561D2
|
cytochrome b561 family, member D2
|
|
CYB5A
|
cytochrome b5 type A (microsomal)
|
|
CYB5R3
|
cytochrome b5 reductase 3
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAZL
|
deleted in azoospermia-like
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DFNY1
|
deafness, Y-linked 1
|
|
DHFRL1
|
dihydrofolate reductase-like 1
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DLAT
|
dihydrolipoamide S-acetyltransferase
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECM1
|
extracellular matrix protein 1
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDN3
|
endothelin 3
|
|
EDNRA
|
endothelin receptor type A
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EP300
|
E1A binding protein p300
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB6
|
EPH receptor B6
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESRP1
|
epithelial splicing regulatory protein 1
|
|
ETFDH
|
electron-transferring-flavoprotein dehydrogenase
|
|
ETV4
|
ets variant 4
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F9
|
coagulation factor IX
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FAM65B
|
family with sequence similarity 65, member B
|
|
FAS
|
Fas cell surface death receptor
|
|
FASN
|
fatty acid synthase
|
|
FBLN5
|
fibulin 5
|
|
FBN1
|
fibrillin 1
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FECD3
|
Corneal dystrophy, Fuchs endothelial, 3
|
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I)
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FH
|
fumarate hydratase
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXC2
|
forkhead box C2
|
|
FOXE1
|
forkhead box E1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRMD7
|
FERM domain containing 7
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABRA6
|
gamma-aminobutyric acid (GABA) A receptor, alpha 6
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF2
|
growth differentiation factor 2
|
|
GDF3
|
growth differentiation factor 3
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GINS2
|
GINS complex subunit 2 (Psf2 homolog)
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GK
|
glycerol kinase
|
|
GLA
|
galactosidase, alpha
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNLY
|
granulysin
|
|
GOLIM4
|
golgi integral membrane protein 4
|
|
GPC3
|
glypican 3
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPX2
|
glutathione peroxidase 2
|
|
GRAMD4
|
GRAM domain containing 4
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2I
|
general transcription factor IIi
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HABP4
|
hyaluronan binding protein 4
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HBZ
|
hemoglobin, zeta
|
|
HDLC3
|
High density lipoprotein cholesterol, low serum, 3
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HM13
|
histocompatibility (minor) 13
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOXB13
|
homeobox B13
|
|
HOXD13
|
homeobox D13
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
HSPA1L
|
heat shock 70kDa protein 1-like
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTT
|
huntingtin
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IGES
|
immunoglobulin E concentration, serum
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGLV@
|
immunoglobulin lambda variable cluster
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INHBC
|
inhibin, beta C
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAG2
|
jagged 2
|
|
JAK2
|
Janus kinase 2
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNIP1
|
Kv channel interacting protein 1
|
|
KCNK10
|
potassium channel, two pore domain subfamily K, member 10
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
KRT8
|
keratin 8, type II
|
|
KRTAP10-1
|
keratin associated protein 10-1
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LCN2
|
lipocalin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LMNA
|
lamin A/C
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAFA
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARC1
|
mitochondrial amidoxime reducing component 1
|
|
MARC2
|
mitochondrial amidoxime reducing component 2
|
|
MB
|
myoglobin
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCHR2
|
melanin-concentrating hormone receptor 2
|
|
MCM5
|
minichromosome maintenance complex component 5
|
|
MCOLN1
|
mucolipin 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEFV
|
Mediterranean fever
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR106B
|
microRNA 106b
|
|
MIR133A1
|
microRNA 133a-1
|
|
MIR141
|
microRNA 141
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146B
|
microRNA 146b
|
|
MIR182
|
microRNA 182
|
|
MIR196B
|
microRNA 196b
|
|
MIR200C
|
microRNA 200c
|
|
MIR21
|
microRNA 21
|
|
MIR224
|
microRNA 224
|
|
MIR27B
|
microRNA 27b
|
|
MIR34A
|
microRNA 34a
|
|
MIR382
|
microRNA 382
|
|
MIR424
|
microRNA 424
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKL2
|
MKL/myocardin-like 2
|
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP17
|
matrix metallopeptidase 17 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MPV17
|
MpV17 mitochondrial inner membrane protein
|
|
MRC1
|
mannose receptor, C type 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT-TL1
|
tRNA
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC13
|
mucin 13, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NES
|
nestin
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOB1
|
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae)
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH4
|
notch 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
OCA2
|
oculocutaneous albinism II
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
OPTN
|
optineurin
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PANX1
|
pannexin 1
|
|
PANX3
|
pannexin 3
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PAPSS1
|
3'-phosphoadenosine 5'-phosphosulfate synthase 1
|
|
PAQR7
|
progestin and adipoQ receptor family member VII
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PAX7
|
paired box 7
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCCA
|
propionyl CoA carboxylase, alpha polypeptide
|
|
PCDH11X
|
protocadherin 11 X-linked
|
|
PCDH11Y
|
protocadherin 11 Y-linked
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE7B
|
phosphodiesterase 7B
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDLIM4
|
PDZ and LIM domain 4
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PER3
|
period circadian clock 3
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLBD2
|
phospholipase B domain containing 2
|
|
PLIN2
|
perilipin 2
|
|
PLIN3
|
perilipin 3
|
|
PLK1
|
polo-like kinase 1
|
|
PLN
|
phospholamban
|
|
PNN
|
pinin, desmosome associated protein
|
|
PODXL
|
podocalyxin-like
|
|
PON1
|
paraoxonase 1
|
|
POU4F3
|
POU class 4 homeobox 3
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R26
|
protein phosphatase 1, regulatory subunit 26
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRND
|
prion protein 2 (dublet)
|
|
PRNP
|
prion protein
|
|
PROKR1
|
prokineticin receptor 1
|
|
PROKR2
|
prokineticin receptor 2
|
|
PROM1
|
prominin 1
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PSENEN
|
presenilin enhancer gamma secretase subunit
|
|
PSRC1
|
proline/serine-rich coiled-coil 1
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTN
|
pleiotrophin
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTX3
|
pentraxin 3, long
|
|
RAB18
|
RAB18, member RAS oncogene family
|
|
RAB6C
|
RAB6C, member RAS oncogene family
|
|
RABL6
|
RAB, member RAS oncogene family-like 6
|
|
RAD51
|
RAD51 recombinase
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELL1
|
RELT-like 1
|
|
RELL2
|
RELT-like 2
|
|
RELT
|
RELT tumor necrosis factor receptor
|
|
RET
|
ret proto-oncogene
|
|
RHOA
|
ras homolog family member A
|
|
RHOC
|
ras homolog family member C
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPSA
|
ribosomal protein SA
|
|
RUMY1
|
regulator of UNG2 and MKLN1 interacting yippee protein 1
|
|
RUMY2
|
RUMY family member 2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAA1
|
serum amyloid A1
|
|
SATB2
|
SATB homeobox 2
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SELE
|
selectin E
|
|
SELENBP1
|
selenium binding protein 1
|
|
SELL
|
selectin L
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
|
|
SHH
|
sonic hedgehog
|
|
SIRPG
|
signal-regulatory protein gamma
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC25A31
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31
|
|
SLC26A9
|
solute carrier family 26 (anion exchanger), member 9
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC28A2
|
solute carrier family 28 (concentrative nucleoside transporter), member 2
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A11
|
solute carrier family 2 (facilitated glucose transporter), member 11
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A8
|
solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SMOX
|
spermine oxidase
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORT1
|
sortilin 1
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRR
|
serine racemase
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR3
|
somatostatin receptor 3
|
|
SSTR5
|
somatostatin receptor 5
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST3GAL5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
SYK
|
spleen tyrosine kinase
|
|
TACR1
|
tachykinin receptor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TBX21
|
T-box 21
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGM2
|
transglutaminase 2
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPO
|
thyroid peroxidase
|
|
TRD
|
T cell receptor delta locus
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTC12
|
tetratricopeptide repeat domain 12
|
|
TTR
|
transthyretin
|
|
TUBA1A
|
tubulin, alpha 1a
|
|
TUBB
|
tubulin, beta class I
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
|
USP1
|
ubiquitin specific peptidase 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VPS33B
|
vacuolar protein sorting 33 homolog B (yeast)
|
|
VWF
|
von Willebrand factor
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XK
|
X-linked Kx blood group
|
|
YAP1
|
Yes-associated protein 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZDHHC13
|
zinc finger, DHHC-type containing 13
|
|
ZDHHC17
|
zinc finger, DHHC-type containing 17
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFP36
|
ZFP36 ring finger protein
|
